Concise, portable, and user-friendly,
The Washington Manual Hematology and Oncology Subspecialty Consult, 5th Edition, provides quick access to the essential information needed to evaluate a patient on a hematology-oncology subspecialty consult service. Edited by Drs. Brian A. Van Tine and Meagan A. Jacoby, this best-selling manual offers state-of-the-art content, including coverage of new therapies such as CAR T-cell therapy, new anti-cancer drugs, and new biomarkers and therapeutic targets. Ideal for fellows, residents, and medical students rotating on hematology and oncology subspecialty services, the manual is also useful as a first-line resource for advanced practice providers, general internal medicine physicians, Hem/ONC fellows, and other primary care providers.
- Thoroughly revised to include new therapies such as PD-1 inhibitors for Hodgkin lymphoma, CAR T-cell therapy in NHL and multiple myeloma, gene therapy for sickle cell disease, CAR T-cell therapies and management of CRS and neurotoxicity, and more
- It presents clinically oriented information like symptoms, signs, and problems in a quick-reference, bulleted list format for easy, everyday reference
- Shares the knowledge and experience of a new co-editor of the Hematology section, Dr. Meagan Jacoby
- Provides updated references for additional information on key topics
- Written by fellows and faculty from the Washington University School of Medicine in St. Louis
The Washington Manual® is a registered mark belonging to Washington University in St. Louis to which international legal protection applies. The mark is used in this publication by WoltersKluwer Health under license from Washington University.
Enrich your eBook reading experience
- Read directly on your preferred device(s),such as computer, tablet, or smartphone.
- Easily convert to audiobook,powering your content with natural language text-to-speech.
Concise, portable, and user-friendly,
The Washington Manual Hematology and Oncology Subspecialty Consult, 5th Edition, provides quick access to the essential information needed to evaluate a patient on a hematology-oncology subspecialty consult service. Edited by Drs. Brian A. Van Tine and Meagan A. Jacoby, this best-selling manual offers state-of-the-art content, including coverage of new therapies such as CAR T-cell therapy, new anti-cancer drugs, and new biomarkers and therapeutic targets. Ideal for fellows, residents, and medical students rotating on hematology and oncology subspecialty services, the manual is also useful as a first-line resource for advanced practice providers, general internal medicine physicians, Hem/ONC fellows, and other primary care providers.
